Stewart Fisher
Chief Tech/Sci/R&D Officer presso C4 THERAPEUTICS, INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Stewart Fisher is currently the Chief Scientific Officer at C4 Therapeutics, Inc. He previously worked as the Executive Director-Infection Bioscience at AstraZeneca PLC from 1988 to 2013.
Additionally, he held the position of Director-Quantitative, Biochemistry & Enzymology at The Broad Institute, Inc. He also served as the Head-Metabolic Diseases Department at Hoffmann-La Roche, Inc. from 1996 to 1998.
Dr. Fisher holds a doctorate degree from the California Institute of Technology and an undergraduate degree from the University of Vermont.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
0.19% | 07/03/2024 | 129 121 ( 0.19% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Stewart Fisher
| Società | Posizione | Inizio |
|---|---|---|
| C4 THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2018 |
Precedenti posizioni note di Stewart Fisher
| Società | Posizione | Fine |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/08/2013 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01/08/1998 |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Stewart Fisher
| California Institute of Technology | Doctorate Degree |
| University of Vermont | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Stewart Fisher
